🔎 Trials Near Me

Akèy › Lymphome de Hodgkin › Kalifòni

Etid klinik pou Lymphome de Hodgkin nan Kalifòni

15 etid pou Lymphome de Hodgkin ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

  • City of Hope Cancer Center (Data Collection Only), Duarte
  • Stanford University Medical Center, Stanford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03618550

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • City of Hope, Duarte
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Duarte
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06137144

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT05272384

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

  • University of California Davis, Davis
  • University of California San Francisco-Fresno, Fresno
  • University of California Irvine, Irvine
  • ak 3 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07021989

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07020533

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  • Stanford University - (Stanford Cancer Institute), Stanford
Ap rekriteFaz 3
Laj 16 a 69 · Tout sèks · Mizajou Jul 8, 2026 · NCT04685616

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • City of Hope, Duarte
  • Children's Hospital of Los Angeles, Glendale
  • Scripps Green Hospital, La Jolla
  • ak 8 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

  • Stanford University Medical Center, Palo Alto
Ap rekriteEtid obsèvasyon
Laj 8 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06098430

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

  • City of Hope National Medical Center, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06915246

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Mar 10, 2026 · NCT06059391

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

  • Stanford University School of Medicine, Stanford
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 24, 2025 · NCT00398177

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 4, 2025 · NCT04871607

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
Ap rekriteFaz 1
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.